PharmaShots: COVID-19 Healthcare News Monthly Updates – June 2020

 PharmaShots: COVID-19 Healthcare News Monthly Updates – June 2020

COVID Updates JUNE

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it. The COVID-19 virus has been named “SARS-CoV-2” (severe acute respiratory syndrome coronavirus 2) and the disease it causes has been named “Coronavirus Disease 2019” (COVID-19). The outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019. Life sciences companies are putting all of their efforts into finding a treatment or developing a vaccine for this disease. PharmaShots is keeping a track of all of the important updates in the Lifesciences sector, where we have covered news updates regarding collaborations, clinical trials, funding, and regulatory guidelines related to the COVID-19 from Jan to date. 

156.  EMA and Korean Ministry of Food and Drug Safety to Share Confidential COVID-19 Information

Jun 30, 2020 | Regulatory

155. TRI Initiates ETHIC Trial to Evaluate the Potential Benefits of Early Administration of LMWH in Patients with COVID-19

Jun 30, 2020 | Clinical Trial

154. Health Canada Allows COVID-19 Patients with Respiratory Failure to Be Given NuvOx Pharma’s Oxygen Therapeutic in P-IIa Clinical Trial

Jun 30, 2020 | Clinical Trial

152. RedHill Biopharma Receives Approval for COVID-19 P-I/II Study with Opaganib in the UK

Jun 29, 2020 | Regulatory

151. Cytocom to Initiate P-II Clinical Trial of CYTO-201 in COVID-19 Patients

Jun 29, 2020 | Clinical Trial

150. US Department of Defense to Fund Altimmune’s P-I/II Study of T-COVID in Outpatients with Early COVID-19

Jun 29, 2020 | Grant

149. RevImmune Initiates P-II Trial of the T-Cell Growth Factor CYT107 for COVID-19

Jun 29, 2020 | Clinical Trial

148. Sanford Burnham Prebys Collaborated with Lilly for COVID-19 Antibody Research

Jun 29, 2020 | Collaboration

147. PEEL Therapeutics Announces New Treatment for COVID-19

Jun 29, 2020 | Clinical Trial

146. Gilead Unveils the Price of Remdesivir as $390 per Vial in Developed Countries

Jun 29, 2020 | Pharma

145. Bharat Biotech to Initiate Clinical Trials Evaluating Covaxin (India’s First COIVD-19 Vaccine) in July 2020

Jun 29, 2020 | Clinical Trial

144. Trial of Oxford’s COVID-19 Vaccine Starts in Brazil

Jun 28, 2020 | Clinical Trial

143. Daiichi Sankyo in Talks with AstraZeneca for the Supply of AZD1222 to Combat COVID-19 in Japan

Jun 29, 2020 | Collaboration

142. EMA Anticipate the EC’s Conditional Marketing Authorization for Gilead’s Remdesivir in Next Week

Jun 25, 2020 | Regulatory

141. LabCorp Launches New Neutralizing Antibody Test for COVID-19

Jun 25, 2020 | Diagnostic

140. Noxopharm to Commence COVID-19 Study in Europe

Jun 25, 2020 | Clinical Trial

139.  Applied Biology Collaborate with Brown University Researchers and Corpometria Institute to Launch ANDROCOV Study for COVID-19

Jun 25, 2020 | Clinical Trial

138. Algernon Receives Ethics Approval for P-IIb/III Study of Ifenprodil for COVID-19

Jun 25, 2020 | Regulatory

137. Avalon GloboCare Achieves Milestones in Advancing Novel Intranasal and Oral COVID-19 Vaccine Candidate

Jun 25, 2020 | Clinical Trial

136. Stevanato Group Signs an Agreement with the CEPI to Provide Pharma Glass Vials for 2B Doses of COVID-19 Vaccine

Jun 25, 2020 | Collaboration

135.  Moderna and Catalent Collaborates for Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate

Jun 25, 2020 | Collaboration

133.  Theravance Reports First Patient Dosing in a P-II Study of TD-0903 for Hospitalized Patients with Acute Lung Injury Associated with COVID-19

Jun 25, 2020 | Clinical Trial

132. Repertoire Immune Medicines Receives Funding From COVID-19 High Performance Computing Consortium

Jun 24, 2020 | Grant

131. UW–Madison and UW Health Launch COVID-19 Clinical Trials

Jun 24, 2020 | Clinical Trials

130. Global Regulators Discuss Data Requirements for P-III Trials of COVID-19 Vaccines

Jun 24, 2020 | Regulatory

129. iBio Selected by IBM Watson Health for the use of IBM Clinical Development Solution at No Cost to help Support clinical COVID-19 Vaccine Candidates

Jun 24, 2020 | Grant

128. ICER Provides First Update to Pricing Models for Remdesivir as a Treatment for COVID-19

Jun 24, 2020 | Regulatory

127.  NeuroRx and Relief Therapeutics Receive the US FDA’s FT Designation for its RLF-100 (Aviptadil) to Treat Respiratory Distress in COVID-19

Jun 24, 2020 | Regulatory

126. Fulcrum Initiates P-III LOSVID Study Evaluating Losmapimod for Patients Hospitalized with COVID-19

Jun 24, 2020 | Clinical Trial

125. Sanofi Anticipates the Approval of its COVID-19 Vaccine by First Half of 2021

Jun 23, 2020 | Clinical Trial

124. AstraZeneca Signs an Agreement with Symbiosis for Sterile Manufacturing of its AZD1222 Against COVID-19

Jun 23, 2020 | Collaboration

123. FibroGen Report Enrollment of First Patient in P-II Study Evaluating Pamrevlumab in Patients Hospitalized with Acute COVID-19

Jun 23, 2020 | Clinical Trial

122.  Frontier Scientific Develops and Provides Process to Produce Active Pharmaceutical Ingredient for Clinical Trial of COVID-19 Therapeutic Investigational Drug RBT-9

Jun 23, 2020 | Clinical Trial

121. Renibus Therapeutics Receives FDA Fast Track Designation for RBT-9 Treatment in COVID-19

Jun 23, 2020 | Regulatory

120. Repurpose.AI and Scripps Research Collaborate to Discover COVID-19 Therapeutics

Jun 23, 2020 | Collaboration

119. Inivio Receives $71M Contract from US Department of Defense to Scale Up Manufacture of CELLECTRA 3PSP Smart Device and Procurement of CELLECTRA 2000 for COVID-19 DNA Vaccine

Jun 23, 2020 | DigiHealth

118. Schrödinger Expands its Drug Discovery Efforts Against COVID-19 Deploying Parallel Computing on Google Cloud

Jun 22, 2020 | DigiHealth

117. Gilead to Initiate P-I Study Evaluating Inhaled Version of Remedesivir Against COVID-19 in August 2020

Jun 22, 2020 | Clinical Trial

116. Feinstein Institutes for Medical Research Finds Extended Drug Treatment Reduces Blood Clots in Discharged Patients, a Side-effect of Recovering COVID-19 Patients

Jun 22, 2020 | Clinical Trial

115.  Evelo Biosciences to Advance EDP1815 into P-II/III TACTIC-E COVID-19 Study

Jun 22, 2020 | Clinical Trial

114. Catalent Collaborates with ViralClear Pharmaceuticals on Potential Treatment for COVID-19

Jun 22, 2020 | Collaboration

113.  Orgenesis and Leidos Collaborate on Potential Treatment for COVID-19

Jun 22, 2020 | Collaboration

112. Glenmark Launches FabiFlu (favipiravir) as the First Oral Medication to Treat Mild to Moderate COVID-19 in India

Jun 20, 2020 | Launch

111. Novartis Halts Clinical Trial Evaluating Hydroxychloroquine Against COVID-19 Due to Slow Enrollment

Jun 20, 2020 | Clinical Trial

110.  Cipla Launches Cipremi (remdesivir lyophilised powder for injection 100 mg) to Treat Patients with Severe COVID-19

Jun 19, 2020 | Launch

109. Ampio to Initiate First Clinical Trial in COVID-19 Program

Jun 19, 2020 | Clinical Trial

108. MMR Vaccine Protects Against the Worst Symptoms of COVID-19

Jun 19, 2020 | Regulatory

107. Ridgeback Launches P-II Study Testing EIDD-2801 as Potential Treatment for COVID-19

Jun 19, 2020 | Clinical Trial

106. NICE Publishes Latest COVID-19 Guidance on Renal Transplantation

Jun 19, 2020 | Regulatory

105. Dynavax Report First Patient Dosing in P-I Clinical Trial Evaluating Clover Biopharmaceuticals’ COVID-19 S-Trimer Vaccine Candidate with CpG 1018 Adjuvant

Jun 19, 2020 | Clinical Trial

104.   WHO Testing Interim Data from COVID-19 Study on HIV drugs

Jun 18, 2020 | Regulatory

103.  Codagenix Reports the Synthesis and Preliminary Safety of Scalable of Vaccine Candidate Against COVID-19

Jun 18, 2020 | Clinical Trial

102.   Tonix Pharmaceuticals and Southern Research Expands its COVID-19 Vaccine Collaboration

Jun 18, 2020 | Collaboration

101.  Roche Rheumatoid Arthritis Drug Fails to Help COVID-19 Patients in Italian study

Jun 18, 2020 | Clinical Trial

100.  National Expansion of Synairgen’s Home-Based COVID-19 Trial of Inhaled SNG001

Jun 18, 2020 | Clinical Trial

99. Enrollment in P-II Clinical Trial in Cystic Fibrosis Has Been Resumed in Israel and Europe After Being Paused Temporarily in Response to the COVID-19 Pandemic

Jun 17, 2020 | Clinical Trial

98.  JW Pharmaceutical to Repurpose Targeted Oncology Drug as COVID-19 Therapy

Jun 17, 2020 | Clinical trial

97.  PTC Therapeutics Initiates P-II/III Clinical Trial to Evaluate PTC299 for the Treatment of COVID-19

Jun 17, 2020 | Clinical trial

96.  Kiniksa Announces Lancet Rheumatology Publication of Clinical Outcomes with Mavrilimumab in COVID-19

Jun 17, 2020 | Clinical trial

95.  Cellics Therapeutics Announces the Publication of Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity in Nano Letters

Jun 17, 2020 | Clinical trial

94.  InflaRx Reports Results from the Exploratory P-II Part of the Adaptive Randomized P-II/III Trial of IFX-1 in COVID-19

Jun 17, 2020 | Clinical trial

93.   Aclaris Therapeutics Supports Investigator-Initiated Clinical Trial of ATI-450 for Cytokine Release Syndrome in Hospitalized Patients with COVID-19

Jun 17, 2020 | Clinical trial

92.  Nascent Biotech to Begin Animal Model Studies for Pritumumab Against Coronaviruses and COVID-19

Jun 17, 2020 | Clinical trial

91.   ViralClear Opens Enrollment with First Patient Dosing in P-II Human Trial of Anti-Viral MMPD Oral Solution for Treatment of COVID-19

Jun 17, 2020 | Clinical trial

90.   Innovation Pharmaceuticals’ Brilacidin Inhibits SARS-CoV-2 (COVID-19) by 97 Percent in a Human Lung Cell Line

Jun 17, 2020 | Clinical trial

89.  CORAT Therapeutics Takes Over the Fast Track Development of a Novel COVID-19 Antibody Drug Program

Jun 17, 2020 | Regulatory

88.   BERG Creates New Drug Research Effort to Use Oak Ridge National Laboratory’s Summit Supercomputer in the Fight Against COVID-19

Jun 17, 2020 | Regulatory

87.   CureVac Receives Regulatory Approval from German and Belgian Authorities to Initiate Phase 1 Clinical Trial of its SARS-CoV-2 Vaccine Candidate

Jun 17, 2020 | Regulatory

86.   Kamada Announces Availability of its Plasma-Derived Hyperimmune IgG Therapy for Coronavirus Disease (COVID-19) for Compassionate Use Treatment in Israel

Jun 17, 2020 | Clinical trial

85.   aTyr Pharma Highlights New Literature Implicating Neuropilin Pathway In SARS-CoV-2 Infection

Jun 17, 2020 | Clinical trial

84.  PDS Biotechnology and Farmacore Biotechnology Announce Co-Development of PDS0204 COVID-19 Vaccine

Jun 17, 2020 | Collaboration

83.   PRA Collaborates with Microsoft to Foster COVID-19 Monitoring

Jun 17, 2020 | DigiHealth

82.   Gilead to Initiate P-II/III Study Evaluating Remdesivir in Pediatric Patients Hospitalized With COVID-19

Jun 17, 2020 | Clinical Trial

81.  AstraZeneca Signs an Agreement with Catalent to Manufacture AZD1222 for COVID-19

Jun 16, 2020 | Collaboration

80. Celltrion Anticipates the Launch of its POCT Kit for COVID-19 in July 2020

Jun 16, 2020 | Diagnostic

79.  AstraZeneca Signs an Agreement with Cobra Biologics for Vaccines Against COVID-19

Jun 16, 2020 | Collaboration

78. TrialSpark Reports the launch of Project Covalence to Rapidly Test Drugs and Diagnostics for COVID-19

Jun 16, 2020 | Diagnostic

77.  Repurposing Approved Drugs for COVID-19 at an Accelerated Pace

Jun 16, 2020 | Clinical Trial

76. Humanigen Reports Additional Analysis of Lenzilumab in Severe and Critical COVID-19 Patients

Jun 16, 2020 | Clinical Trial

75. US Research Program Launches COVID-19 Research Initiatives

Jun 16, 2020 | Regulatory

74.  AGC Biologics to Develop and Produce COVID-19 Vaccine

Jun 16, 2020 | Clinical Trial

73.  Arch Biopartners Receives the US FDA’s Apporval to Intiate P- II Trial Evaluating Metablok (LSALT peptide) for the Treatment of COVID-19 Patients

Jun 16, 2020 | Clinical Trial

72.  Monopar and NorthStar Collaborate to Develop Radio-Immuno-Therapeutics (RITs) Targeting Severe COVID-19

Jun 16, 2020 | Collaboration

71.  aTyr Pharma Reports First Patient Dosing in P-II Trial of ATYR1923 in COVID-19 Patients with Severe Respiratory Complications

Jun 15, 2020 | Clinical Trial

70.  Mayo Clinic Study of Humanigen’s Lenzilumab Shows Rapid Recovery and Discharge in Severe and Critical COVID-19 Patients

Jun 15, 2020 | Clinical Trial

69. Immunic Announces First Patients Dosed in its P-II CALVID-1 Clinical Trial of IMU-838 in COVID-19

Jun 15, 2020 | Clinical Trial

68.  Vaxart to Accelerate Advancement of COVID-19 and Other Programs

Jun 15, 2020 | Clinical Trial

67.  Treos Bio Forms New Subsidiary to Develop a Preventive COVID-19 Peptide Vaccine

Jun 15, 2020 | Pharma

66.  Adamis Pharmaceuticals Signs a License to Commercialize Tempol for the Treatment of Respiratory Diseases Including COVID-19

Jun 15, 2020 | Collaboration

65.  NIH Launches Analytics Platform to Harness Nationwide COVID-19 Patient Data to Speed Treatments

Jun 15, 2020 | Regulatory

64.  Edesa Biotech Receives Regulatory Approval to Initiate COVID-19 Study

Jun 15, 2020 | Clinical Trial

63.  FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine

Jun 15, 2020 | Regulatory

62.  Eli Lilly Initiates P-III Study Evaluating Baricitinib in Hospitalized Patients with COVID-19

Jun 15, 2020 | Clinical Trial

61.  OncoImmune Provides Update on P-III Clinical Trial of CD24Fc for Severe and Critical COVID-19

Jun 14, 2020 | Clinical Trial

60.  AstraZeneca To Supply 400M Doses of Vaccines to IVA by the End of 2020

Jun 13, 2020 | Clinical Trial

59. Sinovac Reports Results of P-I/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19

Jun 13, 2020 | Clinical Trial

58.  Gilead Signs a License Agreement with Zydus and Dr. Reddy’s for Remdesivir to Treat COVID-19

Jun 12, 2020 | Clinical Trial

57.  Daiichi Sankyo to Develop Vaccine for COVID-19 in Japan

Jun 12, 2020 | Clinical Trial

56. Regeneron Initiates its First Clinical Study of Antibody Cocktail for the Treatment and Prevention of COVID-19

Jun 11, 2020 | Clinical Trial

55. Moderna to Initiate P-III Study of its mRNA-1273 Against COVID-19 in July 2020

Jun 11, 2020 | Clinical Trial

54.  Sinovac and Butantan to Advance the Clinical Development of an Inactivated Vaccine for COVID-19 to P-III

Jun 11, 2020 | Collaboration

53.  European Investment Bank Fund ~€100M to BioNTech for COVID-19 Vaccine Development and Manufacturing

Jun 11, 2020 | Grant

52. Celltrion to Evaluate Remsima (biosimilar, infliximab) Against COVID-19 in Britain

Jun 10, 2020 | Clinical Trial

51. Sorrento Submits EUA to the US FDA for its COVI-TRACK Test to Detect COVID-19

Jun 10, 2020 | Diagnostic

50.  Johnson & Johnson to Initiate P-I/IIa Clinical Study of its COVID-19 Vaccine in July

Jun 10, 2020 | Clinical Trial

49.   RedHill Biopharma Reports the Submission of CTA for P-II/III Study Evaluating Opaganib Against COVID-19 in Russia

Jun 10, 2020 | Clinical Trial

48.  Tychan to Initiate Clinical Trials for TY027 Against COVID-19

Jun 10, 2020 | Clinical Trial

47.   NIH-Funded Study to Evaluate Drugs Prescribed to Children with COVID-19

Jun 10, 2020 | Grant

46.  Qualigen Signs Exclusive License Agreement with the University of Louisville to Develop AS1411 Against COVID-19

Jun 10, 2020 | Collaboration

45.  Data Supports Continued Use of ACE inhibitors and ARB medicines During COVID-19 Pandemic

Jun 10, 2020 | Regulatory

44. Fulcrum Therapeutics to Evaluate Losmapimod as Potential Treatment for COVID-19

Jun 10, 2020 | Clinical Trial

43. Panacea Biotech and Refana Announce Collaborates for COVID-19 Vaccine

Jun 10, 2020 | Collaboration

42.  APC Collaborates with Vaxine to Develop COVID-19 Vaccine

Jun 10, 2020 | Collaboration

41.   HSA Grants Conditional Approval of Remdesivir for Treatment of COVID-19 Infection

Jun 10, 2020 | Regulatory

40.   Catalent Collaborates with Spicona to Develop COVID-19 Vaccine Candidate using GPEx Cell Line Development Platform

Jun 10, 2020 | Collaboration

39. Alphamab Oncology and Institut Pasteur Shanghai Collaborate to Co-develop COVID-19 Neutralizing Antibody

Jun 09, 2020 | Collaboration

38. Relief Therapeutics and NeuroRx Expand Clinical Trial of RLF-100 to all patients with Critical COVID-19 and Respiratory Failure

Jun 08, 2020 | Clinical Trial

37. Fujifilm Clinical Research May Drag on into July Against COVID-19

Jun 07, 2020 | Clinical Trial

36. China to Strengthen Global Cooperation in COVID-19 Vaccine Studies

Jun 07, 2020 | Clinical Trial

35. AstraZeneca Reports Results of Calquence (acalabrutinib) in CALAVI Study for Hospitalized COVID-19 Patients

Jun 05, 2020 | Collaboration

34. Oxford Biomedica Signs a Five-Year Agreement with the Vaccines Manufacturing and Innovation Centre (VMIC) for AZD1222

Jun 05, 2020 | Collaboration

33. AbbVie Enters into a Collaboration to Develop Monoclonal Antibody Therapy for Preventing COVID-19

Jun 05, 2020 | Collaboration

32. AstraZeneca Signs an Agreement with Serum Institute to Supply 1B Doses of Oxford University’s COVID-19 Vaccine

Jun 05, 2020 | Collaboration

31. Sun Pharma Initiates P-II Clinical Study of AQCH as Treatment for COVID-19 patients

Jun 05, 2020 | Clinical Trial

30. Sorrento Report Preclinical Results of COVIDTRAP (STI-4398) to Treat COVID-19

Jun 05, 2020 | Clinical Trial

29. ONO Initiates Clinical Studies Evaluating Foipan for COVID-19

Jun 05, 2020 | Clinical Trial

28. The University of Queensland, CEPI and CSL Collaborate to Advance Development and Manufacture of COVID-19 Vaccine Candidate

Jun 05, 2020 | Collaboration

27. ViralClear Expands Patient Enrollment its Planned Phase II Merimepodib for COVID-19

Jun 05, 2020 | Clinical Trial

26. RECOVERY Study Demonstrated No Clinical Benefits for Using Hydroxychloroquine in Hospitalized Patients with COVID-19

Jun 05, 2020 | Clinical Trial

25. Intravacc and EpiVax Collaborate to Develop an Emerging Vaccine for COVID-19

Jun 04, 2020 | Collaboration

24. Inovio to Initiate P-I/II Study of INO-4800 Against COVID-19 in South Korea

Jun 04, 2020 | Clinical Trial

23. Roche’s Elecsys IL-6 Test Receives the US FDA’s EUA to Identify Patients at High Risk of Severe Inflammatory Response with COVID-19

Jun 04, 2020 | Diagnostic

22. Novavax Awarded Department of Defense Contract for COVID-19 Vaccine

Jun 04, 2020 | Collaboration

21. Vapotherm to Expand Production Capacity in Advance of Potential Increase in Demand for High-Flow Nasal Cannula Systems for Treating COVID-19 Respiratory Distress

Jun 04, 2020 | Pharma

20. MyBio to launch Covid-19 antibody test in partnership with MöLab

Jun 04, 2020 | Diagnostic

19. Roche’s COVID-19 Ab Test Receives FDA’s EUA and is Available in Markets Accepting the CE Mark

Jun 04, 2020 | Diagnostic

18.  Novavax Collaborates with AGC Biologics to Manufacture Matrix-M Adjuvant for Novel COVID-19 Vaccine

Jun 03, 2020 | Collaboration

17.  Institutional Review Board (IRB) Review of Individual Patient Expanded Access Requests for Investigational Drugs and Biological Products During the COVID-19 Public Health Emergency Guidance for IRBs and Clinical Investigators

Jun 02, 2020 | Regulatory

16. Cellenkos Reports FDA Clearance to Initiate P-I Study of CK0802 for Treatment of COVID-19 Associated Acute Respiratory Distress Syndrome

Jun 02, 2020 | Regulatory

15. AgeX Therapeutics and ImStem Biotechnology Sign Non-Binding Letter of Intent Regarding Investigational MSC Candidate IMS001 for COVID-19 and Other Causes of ARDS

Jun 02, 2020 | Clinical Trial

14. Trevena Collaborates with Imperial College London to Evaluate TRV027 in COVID-19 Patients

Jun 02, 2020 | Clinical Trial

13. Lonza Sets New Goal to Make Moderna Covid-19 Vaccine Ingredients

Jun 02, 2020 | Clinical Trial

12.   UK’s Recovery Covid-19 Therapy Study Expected in Early July

Jun 02, 2020 | Clinical Trial

11. Gilead’s Remedesivir Receives EUA to Treat Patients with COVID-19

Jun 02, 2020 | Regulatory

10.  Agenus Receives IND Approval for iNKT Cells to Treat COVID-19 Patients

Jun 02, 2020 | Clinical Trial

9.  Bergenbio Dosed First Covid-19 Patient with Bemcentinib in Accord Trial

Jun 02, 2020 | Clinical Trial

7. Eight US Manufacturers Selected to Make NASA COVID-19 Ventilator

Jun 01, 2020 | Diagnostic

6. Genekam Develops Plasma Therapy Accelerator for COVID-19 Patients

Jun 01, 2020 | Diagnostic

5. Siemens Healthineers Receives FDA’s EUA for its SARS-CoV-2 Total Antibody Test that Delivers Superior Clinical Performance

Jun 01, 2020 | Diagnostic

4. Sema4 to Deliver High Capacity COVID-19 Testing in Partnership with the State of Connecticut

Jun 01, 2020 | Diagnostic

3. Eli Lilly Initiates the World’s First Clinical Study to Evaluate the Potential of COVID-19 Antibody Treatment in Humans

Jun 01, 2020 | Clinical Trial

2. Abiomed Receives EUA For Impella RP As Therapy For COVID-19 Patients with Right Heart Failure

Jun 01, 2020 | Regulatory

1. Gilead’s Remdesivir Shows Benefit in Patients with Moderate Covid-19

Jun 01, 2020 | Clinical Trial

Related Post: Insights+ Exclusive: COVID-19 Healthcare News Monthly Updates – May 2020

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post